Qun-ying Yue
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Pharmacogenetics of metamizole-induced agranulocytosis: a systematic review and drug regulation implications.
Journal: Frontiers in pharmacology
Published: May 06, 2025
Dabigatran-related serious medication errors: an analysis using data from VigiBase.
Journal: European journal of clinical pharmacology
Published: April 25, 2023
Montelukast and Nightmares: Further Characterisation Using Data from VigiBase.
Journal: Drug safety
Published: April 26, 2022
Fatal adverse events of rivaroxaban combined with aspirin: an analysis using data from VigiBase.
Journal: European journal of clinical pharmacology
Published: February 14, 2022
Indapamide-Induced Rhabdomyolysis: An Evaluation of Case Reports in VigiBase Using the Bradford Hill Criteria.
Journal: Drugs - real world outcomes
Published: February 08, 2022
Global safety monitoring of COVID-19 vaccines: how pharmacovigilance rose to the challenge.
Journal: Therapeutic advances in drug safety
Published: September 27, 2021
Fatal Adverse Events of Dabigatran Combined With Aspirin in Elderly Patients: An Analysis Using Data From VigiBase.
Journal: Frontiers in pharmacology
Published: September 01, 2021
Appendicitis as a possible safety signal for the COVID-19 vaccines.
Journal: Vaccine: X
Published: June 22, 2021
Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase.
Journal: The European respiratory journal
Published: March 31, 2021
The International Society of Pharmacovigilance (ISoP) Pharmacogenomic Special Interest Group: Pharmacogenomics in Pharmacovigilance.
Journal: Drug safety
Published: March 30, 2021
Tumor necrosis factor inhibitor-induced pleuropericarditis: A retrospective evaluation using data from VigiBase.
Journal: International immunopharmacology
Published: July 03, 2020
Exome Sequencing Reveals Common and Rare Variants in F5 Associated With ACE Inhibitor and Angiotensin Receptor Blocker-Induced Angioedema.
Journal: Clinical pharmacology and therapeutics
Published: February 20, 2020
Last Updated: 09/26/2026